» Articles » PMID: 19528236

Neuronal Protein Tyrosine Phosphatase 1B Deficiency Results in Inhibition of Hypothalamic AMPK and Isoform-specific Activation of AMPK in Peripheral Tissues

Abstract

PTP1B(-/-) mice are resistant to diet-induced obesity due to leptin hypersensitivity and consequent increased energy expenditure. We aimed to determine the cellular mechanisms underlying this metabolic state. AMPK is an important mediator of leptin's metabolic effects. We find that alpha1 and alpha2 AMPK activity are elevated and acetyl-coenzyme A carboxylase activity is decreased in the muscle and brown adipose tissue (BAT) of PTP1B(-/-) mice. The effects of PTP1B deficiency on alpha2, but not alpha1, AMPK activity in BAT and muscle are neuronally mediated, as they are present in neuron- but not muscle-specific PTP1B(-/-) mice. In addition, AMPK activity is decreased in the hypothalamic nuclei of neuronal and whole-body PTP1B(-/-) mice, accompanied by alterations in neuropeptide expression that are indicative of enhanced leptin sensitivity. Furthermore, AMPK target genes regulating mitochondrial biogenesis, fatty acid oxidation, and energy expenditure are induced with PTP1B inhibition, resulting in increased mitochondrial content in BAT and conversion to a more oxidative muscle fiber type. Thus, neuronal PTP1B inhibition results in decreased hypothalamic AMPK activity, isoform-specific AMPK activation in peripheral tissues, and downstream gene expression changes that promote leanness and increased energy expenditure. Therefore, the mechanism by which PTP1B regulates adiposity and leptin sensitivity likely involves the coordinated regulation of AMPK in hypothalamus and peripheral tissues.

Citing Articles

SF1-specific deletion of the energy sensor AMPKγ2 induces obesity.

Freire-Agulleiro O, Estevez-Salguero A, Ferreira V, Holleman C, Garcia-Curras J, Gonzalez-Garcia I Mol Metab. 2025; 92:102091.

PMID: 39746605 PMC: 11782900. DOI: 10.1016/j.molmet.2024.102091.


Rheumatic diseases and metabolism: where centre and periphery meet.

Lopez M, Gualillo O Nat Rev Rheumatol. 2024; 20(12):783-794.

PMID: 39478099 DOI: 10.1038/s41584-024-01178-6.


Association between PTPN1 polymorphisms and obesity-related phenotypes in European adolescents: influence of physical activity.

Salazar-Tortosa D, Labayen I, Gonzalez-Gross M, Seral-Cortes M, Moreno L, Zapico A Pediatr Res. 2022; 93(7):2036-2044.

PMID: 36369476 DOI: 10.1038/s41390-022-02377-1.


Evidence for a neuromuscular circuit involving hypothalamic interleukin-6 in the control of skeletal muscle metabolism.

Katashima C, de Oliveira Micheletti T, Braga R, Gaspar R, Goeminne L, Moura-Assis A Sci Adv. 2022; 8(30):eabm7355.

PMID: 35905178 PMC: 9337767. DOI: 10.1126/sciadv.abm7355.


Targeting Breast Cancer and Their Stem Cell Population through AMPK Activation: Novel Insights.

Uprety B, Abrahamse H Cells. 2022; 11(3).

PMID: 35159385 PMC: 8834477. DOI: 10.3390/cells11030576.


References
1.
Sakamoto K, Zarrinpashneh E, Budas G, Pouleur A, Dutta A, Prescott A . Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1. Am J Physiol Endocrinol Metab. 2005; 290(5):E780-8. PMC: 2128705. DOI: 10.1152/ajpendo.00443.2005. View

2.
Rondinone C, Trevillyan J, Clampit J, Gum R, Berg C, Kroeger P . Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis. Diabetes. 2002; 51(8):2405-11. DOI: 10.2337/diabetes.51.8.2405. View

3.
Winder W, Hardie D . AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol. 1999; 277(1):E1-10. DOI: 10.1152/ajpendo.1999.277.1.E1. View

4.
Zinker B, Rondinone C, Trevillyan J, Gum R, Clampit J, Waring J . PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc Natl Acad Sci U S A. 2002; 99(17):11357-62. PMC: 123261. DOI: 10.1073/pnas.142298199. View

5.
Lee W, Kim M, Park H, Kim H, Jeon M, Oh K . AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. Biochem Biophys Res Commun. 2005; 340(1):291-5. DOI: 10.1016/j.bbrc.2005.12.011. View